Citation

Das S, Saha I, Mondal S, Bandyopadhyay S. J. Young Pharm. 2013; 5(3): 108-109.

Copyright

(Copyright © 2013)

DOI

10.1016/j.jyp.2013.08.003

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

adolescent; adult; human; suicide; schizophrenia; anxiety; fatigue; cholesterol blood level; clinical article; triacylglycerol; drug metabolism; cognitive defect; sedation; tachycardia; xerostomia; neutropenia; priority journal; somnolence; letter; orthostatic hypotension; cholesterol; placebo; extrapyramidal symptom; drug tolerability; weight gain; agranulocytosis; leukopenia; hyperprolactinemia; serotoninergic system; akathisia; side effect; glucose blood level; ziprasidone; QT prolongation; cytochrome P450 3A4; drug half life; glucose; hypoglycemia; adrenergic system; motor dysfunction; dizziness; neuroleptic malignant syndrome; triacylglycerol blood level; single nucleotide polymorphism; dopaminergic system; drug dose increase; drug dose titration; cytochrome P450 2D6; priapism; nose obstruction; drug transformation; iloperidone